Význam genotypu a fenotypu CYP2D6 při léčbě paroxetinem

Warning

This publication doesn't include Faculty of Arts. It includes Faculty of Medicine. Official publication website can be found on muni.cz.
Title in English Impact of genotype and phenotype CYP2D6 in paroxetine treatment
Authors

ŽOURKOVÁ Alexandra HADAŠOVÁ Eva PILAŘOVÁ Lucie RAVČUKOVÁ Barbora ROBEŠ Miroslav

Year of publication 2005
Type Article in Periodical
Magazine / Source Psychiatrie časopis pro moderní psychiatrii
MU Faculty or unit

Faculty of Medicine

Citation
Field Psychiatry, sexuology
Keywords genotype-phenotype-CYP2D6-paroxetine-sexual dysfunction
Description The aim of study was comparison of distribution of therapeutic efficacy and side effects including sexual dysfunction in long term paroxetine treatment within 50 patients genotyped and phenotyped to determine their CYP2D6 metabolic status.No variation in therapeutic efficaccy and common adverse effects between subjects classified as PM and those marked as EM was found. A significantly higher rate of sexual dysfunction was recorded among patients with a PM phenotype.
Related projects:

You are running an old browser version. We recommend updating your browser to its latest version.